Parps and adp-ribosylation: Recent advances linking molecular functions to biological outcomes

Genes and Development

Volumn 31, Issue 2, 2017, Pages 101-126

  Gupte, Rebecca ^a,b   Liu, Ziying ^a,b   Kraus, W Lee ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

DNA repair; Gene regulation; Mono(ADP ribose) (MAR); Poly (ADP ribose) polymerase (PARP); Poly(ADP ribose) (PAR); RNA biology

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; CELL DEATH; CELL SURVIVAL; CHROMATIN STRUCTURE; CLICK CHEMISTRY; DNA REPAIR; DNA TRANSCRIPTION; GENE CONTROL; GENOMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEOMICS; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; MOLECULAR BIOLOGY; TRENDS;

ANIMALS; DNA REPAIR; ENZYME ACTIVATION; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR BIOLOGY; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 85014121562     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.291518.116     Document Type: Review

References (217)

1. Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 13: 720–731.
2. Adhya D, Basu A. 2010. Epigenetic modulation of host: new insights into immune evasion by viruses. J Biosci 35: 647–663.
3. Aguilar-Quesada R, Munoz-Gamez JA, Martin-Oliva D, Peralta A, Valenzuela MT, Matinez-Romero R, Quiles-Perez R, Menissier-de Murcia J, de Murcia G, Ruiz de Almodovar M, et al. 2007. Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition. BMC Mol Biol 8: 29.
4. Aguilera-Gomez A, van Oorschot MM, Veenendaal T, Rabouille C. 2016. In vivo vizualisation of mono-ADP-ribosylation by dPARP16 upon amino-acid starvation. Elife 5: e21475.
5. Ahel I, Ahel D, Matsusaka T, Clark AJ, Pines J, Boulton SJ, West SC. 2008. Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature 451: 81–85.
6. Ahel D, Horejsi Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP, et al. 2009. Poly (ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325: 1240–1243.
7. Aksoy P, Escande C, White TA, Thompson M, Soares S, Benech JC, Chini EN. 2006a. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem Biophys Res Commun 349: 353–359.
8. Aksoy P, White TA, Thompson M, Chini EN. 2006b. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem Biophys Res Commun 345: 1386–1392.
9. Altmeyer M, Neelsen KJ, Teloni F, Pozdnyakova I, Pellegrino S, Grofte M, Rask MB, Streicher W, Jungmichel S, Nielsen ML, et al. 2015. Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat Commun 6: 8088.
10. Ame JC, Spenlehauer C, de Murcia G. 2004. The PARP superfam-ily. Bioessays 26: 882–893.
11. + levels. J Biol Chem 277: 18881–18890.
12. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Sinclair DA. 2003. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423: 181–185.
13. Araki T, Sasaki Y, Milbrandt J. 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305: 1010–1013.
14. Audebert M, Salles B, Calsou P. 2004. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 279: 55117–55126.
15. Barbarulo A, Iansante V, Chaidos A, Naresh K, Rahemtulla A, Franzoso G, Karadimitris A, Haskard DO, Papa S, Bubici C. 2013. Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-sur-vival signal in multiple myeloma. Oncogene 32: 4231–4242.
16. Barkauskaite E, Jankevicius G, Ladurner AG, Ahel I, Timinszky G. 2013. The recognition and removal of cellular poly(ADP-ri-bose) signals. FEBS J 280: 3491–3507.
17. Bartolomei G, Leutert M, Manzo M, Baubec T, Hottiger MO. 2016. Analysis of chromatin ADP-ribosylation at the ge-nome-wide level and at specific loci by ADPr-ChAP. Mol Cell 61: 474–485.
18. Beck C, Boehler C, Guirouilh Barbat J, Bonnet ME, Illuzzi G, Ronde P, Gauthier LR, Magroun N, Rajendran A, Lopez BS, et al. 2014a. PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways. Nucleic Acids Res 42: 5616–5632.
19. Beck C, Robert I, Reina-San-Martin B, Schreiber V, Dantzer F. 2014b. Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3. Exp Cell Res 329: 18–25.
20. Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, Lukas J. 2006. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol 173: 195–206.
21. Berger F, Lau C, Dahlmann M, Ziegler M. 2005. Subcellular com-partmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280: 36334–36341.
22. Boamah EK, Kotova E, Garabedian M, Jarnik M, Tulin AV. 2012. Poly(ADP-Ribose) polymerase 1 (PARP-1) regulates ribosomal biogenesis in Drosophila nucleoli. PLoS Genet 8: e1002442.
23. Boehler C, Gauthier LR, Mortusewicz O, Biard DS, Saliou JM, Bresson A, Sanglier-Cianferani S, Smith S, Schreiber V, Boussin F, et al. 2011. Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression. Proc Natl Acad Sci 108: 2783–2788.
24. Brown JS, Kaye SB, Yap TA. 2016. PARP inhibitors: the race is on. Br J Cancer 114: 713–715.
25. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T. 2005. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913–917.
26. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, et al. 2012. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov 2: 798–811.
27. +. Science 352: 1474–1477.
28. Cardnell RJ, Feng Y, Diao L, Fan YH, Masrorpour F, Wang J, Shen Y, Mills GB, Minna JD, Heymach JV, et al. 2013. Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer. Clin Cancer Res 19: 6322–6328.
29. Cardnell RJ, Feng Y, Mukherjee S, Diao L, Tong P, Stewart CA, Masrorpour F, Fan Y, Nilsson M, Shen Y, et al. 2016. Activation of the PI3K/mTOR pathway following PARP inhibition in small cell lung cancer. PLoS One 11: e0152584.
30. Carter-O’Connell I, Jin H, Morgan RK, David LL, Cohen MS. 2014. Engineering the substrate specificity of ADP-ribosyl-transferases for identifying direct protein targets. J Am Chem Soc 136: 5201–5204.
31. Carter-O’Connell I, Jin H, Morgan RK, Zaja R, David LL, Ahel I, Cohen MS. 2016. Identifying family-member-specific targets of mono-ARTDs by using a chemical genetics approach. Cell Rep 14: 621–631.
32. Chapman JD, Gagne JP, Poirier GG, Goodlett DR. 2013. Mapping PARP-1 auto-ADP-ribosylation sites by liquid chro-matography-tandem mass spectrometry. J Proteome Res 12: 1868–1880.
33. Cho YS, Han MK, Kwark OS, Phoe MS, Cha YS, An NH, Kim UH. 1998. Auto-ADP-ribosylation of NAD glycohydrolase from Neurospora crassa. Comp Biochem Physiol B Biochem Mol Biol 120: 175–181.
34. Cho SH, Ahn AK, Bhargava P, Lee CH, Eischen CM, McGuinness O, Boothby M. 2011. Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family. Proc Natl Acad Sci 108: 15972– 15977.
35. Cho SH, Raybuck A, Wei M, Erickson J, Nam KT, Cox RG, Troch-tenberg A, Thomas JW, Williams J, Boothby M. 2013. B cell-in-trinsic and -extrinsic regulation of antibody responses by PARP14, an intracellular (ADP-ribosyl)transferase. J Immunol 191: 3169–3178.
36. Chou DM, Adamson B, Dephoure NE, Tan X, Nottke AC, Hurov KE, Gygi SP, Colaiacovo MP, Elledge SJ. 2010. A chromatin localization screen reveals poly (ADP ribose)-regulated recruit- ment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proc Natl Acad Sci 107: 18475–18480.
37. Curtin NJ, Szabo C. 2013. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med 34: 1217–1256.
38. Daniels CM, Ong SE, Leung AK. 2014. Phosphoproteomic approach to characterize protein mono- and poly(ADP-ribosyl) ation sites from cells. J Proteome Res 13: 3510–3522.
39. Daniels CM, Ong SE, Leung AK. 2015a. The promise of proteomics for the study of ADP-ribosylation. Mol Cell 58: 911–924.
40. Daniels CM, Thirawatananond P, Ong SE, Gabelli SB, Leung AK. 2015b. Nudix hydrolases degrade protein-conjugated ADP-ribose. Sci Rep 5: 18271.
41. Daugherty MD, Malik HS. 2012. Rules of engagement: molecular insights from host-virus arms races. Annu Rev Genet 46: 677–700.
42. Daugherty MD, Young JM, Kerns JA, Malik HS. 2014. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts. PLoS Genet 10: e1004403.
43. David KK, Andrabi SA, Dawson TM, Dawson VL. 2009. Parthana-tos, a messenger of death. Front Biosci (Landmark Ed) 14: 1116–1128.
44. Dawicki-McKenna JM, Langelier MF, DeNizio JE, Riccio AA, Cao CD, Karch KR, McCauley M, Steffen JD, Black BE, Pascal JM. 2015. PARP-1 activation requires local unfolding of an autoinhibitory domain. Mol Cell 60: 755–768.
45. de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, et al. 1997. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci 94: 7303–7307.
46. De Vos M, Schreiber V, Dantzer F. 2012. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol 84: 137–146.
47. Dotti CG, Sullivan CA, Banker GA. 1988. The establishment of polarity by hippocampal neurons in culture. J Neurosci 8: 1454–1468.
48. Drew Y, Calvert H. 2008. The potential of PARP inhibitors in genetic breast and ovarian cancers. Ann N Y Acad Sci 1138: 136–145.
49. Drew Y, Ledermann J, Hall G, Rea D, Glasspool R, Highley M, Jayson G, Sludden J, Murray J, Jamieson D, et al. 2016. Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. Br J Cancer 114: 723–730.
50. Egloff MP, Malet H, Putics A, Heinonen M, Dutartre H, Frangeul A, Gruez A, Campanacci V, Cambillau C, Ziebuhr J, et al. 2006. Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains. J Virol 80: 8493–8502.
51. El Ramy R, Magroun N, Messadecq N, Gauthier LR, Boussin FD, Kolthur-Seetharam U, Schreiber V, McBurney MW, Sassone-Corsi P, Dantzer F. 2009. Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes. Cell Mol Life Sci 66: 3219–3234.
52. Emanuelli M, Carnevali F, Saccucci F, Pierella F, Amici A, Raffaelli N, Magni G. 2001. Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J Biol Chem 276: 406–412.
53. Eustermann S, Wu WF, Langelier MF, Yang JC, Easton LE, Riccio AA, Pascal JM, Neuhaus D. 2015. Structural basis of detection and signaling of DNA single-strand breaks by human PARP-1. Mol Cell 60: 742–754.
54. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, et al. 2005. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917–921.
55. Farrar D, Rai S, Chernukhin I, Jagodic M, Ito Y, Yammine S, Ohls-son R, Murrell A, Klenova E. 2010. Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation. Mol Cell Biol 30: 1199–1216.
56. Feijs KL, Forst AH, Verheugd P, Luscher B. 2013. Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation. Nat Rev Mol Cell Biol 14: 443–451.
57. Fenton AL, Shirodkar P, Macrae CJ, Meng L, Koch CA. 2013. The PARP3- and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair. Nucleic Acids Res 41: 4080–4092.
58. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O’Connor MJ, et al. 2009. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123–134.
59. Franco HL, Kraus WL. 2015. No driver behind the wheel? Targeting transcription in cancer. Cell 163: 28–30.
60. Gagne JP, Isabelle M, Lo KS, Bourassa S, Hendzel MJ, Dawson VL, Dawson TM, Poirier GG. 2008. Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-as-sociated protein complexes. Nucleic Acids Res 36: 6959–6976.
61. Gagne JP, Ethier C, Defoy D, Bourassa S, Langelier MF, Riccio AA, Pascal JM, Moon KM, Foster LJ, Ning Z, et al. 2015. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs. DNA Repair (Amst) 30: 68–79.
62. Gao G, Guo X, Goff SP. 2002. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297: 1703–1706.
63. Gao F, Kwon SW, Zhao Y, Jin Y. 2009. PARP1 poly(ADP-ribosyl) ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. J Biol Chem 284: 22263–22273.
64. Gaszner M, Felsenfeld G. 2006. Insulators: exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 7: 703–713.
65. + glycohydrolase: re-evaluation of enzymatic properties associated with pathogenesis. J Biol Chem 285: 5683–5694.
66. Gibbs-Seymour I, Fontana P, Rack JG, Ahel I. 2016. HPF1/ C4orf27 is a PARP-1-interacting protein that regulates PARP-1 ADP-ribosylation activity. Mol Cell 62: 432–442.
67. Gibson BA, Kraus WL. 2012. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13: 411–424.
68. Gibson BA, Zhang Y, Jiang H, Hussey KM, Shrimp JH, Lin H, Schwede F, Yu Y, Kraus WL. 2016. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. Science 353: 45–50.
69. Goodier JL, Pereira GC, Cheung LE, Rose RJ, Kazazian HH Jr. 2015. The broad-spectrum antiviral protein ZAP restricts human retrotransposition. PLoS Genet 11: e1005252.
70. Gottschalk AJ, Timinszky G, Kong SE, Jin J, Cai Y, Swanson SK, Washburn MP, Florens L, Ladurner AG, Conaway JW, et al. 2009. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc Natl Acad Sci 106: 13770–13774.
71. Grady SL, Hwang J, Vastag L, Rabinowitz JD, Shenk T. 2012. Herpes simplex virus 1 infection activates poly(ADP-ribose) poly- merase and triggers the degradation of poly(ADP-ribose) glycohydrolase. J Virol 86: 8259–8268.
72. Grundy GJ, Polo LM, Zeng Z, Rulten SL, Hoch NC, Paomephan P, Xu Y, Sweet SM, Thorne AW, Oliver AW, et al. 2016. PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2B(Glu2). Nat Commun 7: 12404.
73. Guetg C, Scheifele F, Rosenthal F, Hottiger MO, Santoro R. 2012. Inheritance of silent rDNA chromatin is mediated by PARP1 via noncoding RNA. Mol Cell 45: 790–800.
74. Haigis MC, Sinclair DA. 2010. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5: 253–295.
75. Haikarainen T, Narwal M, Joensuu P, Lehtio L. 2014. Evaluation and structural basis for the inhibition of tankyrases by PARP inhibitors. ACS Med Chem Lett 5: 18–22.
76. Haince JF, Kozlov S, Dawson VL, Dawson TM, Hendzel MJ, Lavin MF, Poirier GG. 2007. Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents. J Biol Chem 282: 16441–16453.
77. Haince JF, McDonald D, Rodrigue A, Dery U, Masson JY, Hendzel MJ, Poirier GG. 2008. PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J Biol Chem 283: 1197–1208.
78. Hassa PO, Hottiger MO. 2002. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders. Cell Mol Life Sci 59: 1534–1553.
79. Hassa PO, Buerki C, Lombardi C, Imhof R, Hottiger MO. 2003. Transcriptional coactivation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 278: 45145–45153.
80. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H, Gersbach M, Imhof R, Hottiger MO. 2005. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-κB-dependent transcription. J Biol Chem 280: 40450–40464.
81. Hassa PO, Covic M, Bedford MT, Hottiger MO. 2008. Protein ar-ginine methyltransferase 1 coactivates NF-κB-dependent gene expression synergistically with CARM1 and PARP1. J Mol Biol 377: 668–678.
82. Hoff KG, Wolberger C. 2005. Getting a grip on O-acetyl-ADP-ribose. Nat Struct Mol Biol 12: 560–561.
83. Hottiger MO. 2015. SnapShot: ADP-ribosylation signaling. Mol Cell 58: 1134–1134 e1131.
84. Hottiger MO, Hassa PO, Luscher B, Schuler H, Koch-Nolte F. 2010. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 35: 208–219.
85. Huang JY, Wang K, Vermehren-Schmaedick A, Adelman JP, Cohen MS. 2016a. PARP6 is a regulator of hippocampal dendritic morphogenesis. Sci Rep 6: 18512.
86. Huang X, Motea EA, Moore ZR, Yao J, Dong Y, Chakrabarti G, Kilgore JA, Silvers MA, Patidar PL, Cholka A, et al. 2016b. Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly(ADP-ribose) polymerase inhibitors. Cancer Cell 30: 940–952.
87. + redox state with a genetically encoded fluorescent biosensor. Cell Metab 14: 545–554.
88. Hussey KM, Chen H, Yang C, Park E, Hah N, Erdjument-Bromage H, Tempst P, Gamble MJ, Kraus WL. 2014. The histone variant macroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1. Mol Cell Biol 34: 2437–2449.
89. Hyman AA, Simons K. 2012. Cell biology. Beyond oil and water— phase transitions in cells. Science 337: 1047–1049.
90. Iwata H, Goettsch C, Sharma A, Ricchiuto P, Goh WW, Halu A, Yamada I, Yoshida H, Hara T, Wei M, et al. 2016. PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADPribosylation. Nat Commun 7: 12849.
91. Jankevicius G, Hassler M, Golia B, Rybin V, Zacharias M, Timinszky G, Ladurner AG. 2013. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation. Nat Struct Mol Biol 20: 508–514.
92. Jankevicius G, Ariza A, Ahel M, Ahel I. 2016. The toxin-antitoxin system DarTG catalyzes reversible ADP-ribosylation of DNA. Mol Cell 64: 1109–1116.
93. Janssen OE, Hilz H. 1989. Differentiation of 3T3-L1 pre-adipo-cytes induced by inhibitors of poly(ADP-ribose) polymerase and by related noninhibitory acids. Eur J Biochem 180: 595–602.
94. Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG. 2006. A topoisomerase IIβ-mediated dsDNA break required for regulated transcription. Science 312: 1798–1802.
95. Jungmichel S, Rosenthal F, Altmeyer M, Lukas J, Hottiger MO, Nielsen ML. 2013. Proteome-wide identification of poly (ADP-ribosyl)ation targets in different genotoxic stress responses. Mol Cell 52: 272–285.
96. Jwa M, Chang P. 2012. PARP16 is a tail-anchored endoplasmic re-ticulum protein required for the PERK- and IRE1α-mediated unfolded protein response. Nat Cell Biol 14: 1223–1230.
97. Kalisch T, Ame JC, Dantzer F, Schreiber V. 2012. New readers and interpretations of poly(ADP-ribosyl)ation. Trends Biochem Sci 37: 381–390.
98. Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M, Fukasawa K. 2007. Inhibition of Crm1–p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nat Cell Biol 9: 1175–1183.
99. Kang HC, Lee YI, Shin JH, Andrabi SA, Chi Z, Gagne JP, Lee Y, Ko HS, Lee BD, Poirier GG, et al. 2011. Iduna is a poly(ADP-ri-bose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage. Proc Natl Acad Sci 108: 14103–14108.
100. Karlberg T, Langelier MF, Pascal JM, Schuler H. 2013. Structural biology of the writers, readers, and erasers in mono- and poly (ADP-ribose) mediated signaling. Mol Aspects Med 34: 1088–1108.
101. Karras GI, Kustatscher G, Buhecha HR, Allen MD, Pugieux C, Sait F, Bycroft M, Ladurner AG. 2005. The macro domain is an ADP-ribose binding module. EMBO J 24: 1911–1920.
102. Kashima L, Idogawa M, Mita H, Shitashige M, Yamada T, Ogi K, Suzuki H, Toyota M, Ariga H, Sasaki Y, et al. 2012. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation. J Biol Chem 287: 12975–12984.
103. Kawamitsu H, Hoshino H, Okada H, Miwa M, Momoi H, Sugi-mura T. 1984. Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. Biochemistry 23: 3771–3777.
104. + glycohydrolase from rabbit erythrocytes is solubilized by phosphatidylinositol-specific phospholipase C. Biochim Biophys Acta 965: 76–81.
105. Kim UH, Kim MK, Kim JS, Han MK, Park BH, Kim HR. 1993. Purification and characterization of NAD glycohydrolase from rabbit erythrocytes. Arch Biochem Biophys 305: 147–152.
106. +-de-pendent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119: 803–814.
107. + into a nuclear signal. Genes Dev 19: 1951–1967.
108. Kistemaker HA, van Noort GJ, Overkleeft HS, van der Marel GA, Filippov DV. 2013. Stereoselective ribosylation of amino acids. Org Lett 15: 2306–2309.
109. Kistemaker HA, Nardozza AP, Overkleeft HS, van der Marel GA, Ladurner AG, Filippov DV. 2016. Synthesis and macrodomain binding of mono-ADP-ribosylated peptides. Angew Chem Int Ed Engl 55: 10634–10638.
110. Koh DW, Lawler AM, Poitras MF, Sasaki M, Wattler S, Nehls MC, Stoger T, Poirier GG, Dawson VL, Dawson TM. 2004. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc Natl Acad Sci 101: 17699–17704.
111. Kolthur-Seetharam U, Dantzer F, McBurney MW, de Murcia G, Sassone-Corsi P. 2006. Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle 5: 873–877.
112. Kraus WL, Lis JT. 2003. PARP goes transcription. Cell 113: 677–683.
113. Krietsch J, Rouleau M, Pic E, Ethier C, Dawson TM, Dawson VL, Masson JY, Poirier GG, Gagne JP. 2013. Reprogramming cellular events by poly(ADP-ribose)-binding proteins. Mol Aspects Med 34: 1066–1087.
114. Krishnakumar R, Kraus WL. 2010a. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 39: 8–24.
115. Krishnakumar R, Kraus WL. 2010b. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 39: 736–749.
116. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M, Kraus WL. 2008. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319: 819–821.
117. Kuny CV, Sullivan CS. 2016. Virus–host interactions and the ARTD/PARP family of enzymes. PLoS Pathog 12: e1005453.
118. Kustatscher G, Hothorn M, Pugieux C, Scheffzek K, Ladurner AG. 2005. Splicing regulates NAD metabolite binding to histone macroH2A. Nat Struct Mol Biol 12: 624–625.
119. Langelier MF, Ruhl DD, Planck JL, Kraus WL, Pascal JM. 2010. The Zn3 domain of human poly(ADP-ribose) polymerase-1 (PARP-1) functions in both DNA-dependent poly(ADP-ribose) synthesis activity and chromatin compaction. J Biol Chem 285: 18877–18887.
120. Langelier MF, Planck JL, Roy S, Pascal JM. 2011. Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity. J Biol Chem 286: 10690–10701.
121. Langelier MF, Planck JL, Roy S, Pascal JM. 2012. Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1. Science 336: 728–732.
122. Langelier MF, Riccio AA, Pascal JM. 2014. PARP-2 and PARP-3 are selectively activated by 5’ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1. Nucleic Acids Res 42: 7762–7775.
123. Lehtio L, Jemth AS, Collins R, Loseva O, Johansson A, Markova N, Hammarstrom M, Flores A, Holmberg-Schiavone L, Wei-gelt J, et al. 2009. Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3. J Med Chem 52: 3108–3111.
124. Leidecker O, Bonfiglio JJ, Colby T, Zhang Q, Atanassov I, Zaja R, Palazzo L, Stockum A, Ahel I, Matic I. 2016. Serine is a new target residue for endogenous ADP-ribosylation on histones. Nat Chem Biol 12: 998–1000.
125. Leung AK, Vyas S, Rood JE, Bhutkar A, Sharp PA, Chang P. 2011. Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell 42: 489–499.
126. Li GY, McCulloch RD, Fenton AL, Cheung M, Meng L, Ikura M, Koch CA. 2010. Structure and identification of ADP-ribose recognition motifs of APLF and role in the DNA damage response. Proc Natl Acad Sci 107: 9129–9134.
127. Li M, Lu LY, Yang CY, Wang S, Yu X. 2013. The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response. Genes Dev 27: 1752–1768.
128. Li C, Debing Y, Jankevicius G, Neyts J, Ahel I, Coutard B, Canard B. 2016. Viral macro domains reverse protein ADP-ribosylation. J Virol 90: 8478–8486.
129. Lin H. 2007. Nicotinamide adenine dinucleotide: beyond a redox coenzyme. Org Biomol Chem 5: 2541–2554.
130. Liu Z, Kraus WL. 2017. Catalytic-independent functions of PARP-1 determine Sox2 pioneer activity at intractable genomic loci. Mol Cell (in press).
131. Luijsterburg MS, de Krijger I, Wiegant WW, Shah RG, Smeenk G, de Groot AJ, Pines A, Vertegaal AC, Jacobs JJ, Shah GM, et al. 2016. PARP1 links CHD2-mediated chromatin expansion and H3.3 deposition to DNA repair by non-homologous end-joining. Mol Cell 61: 547–562.
132. Luo X, Kraus WL. 2012. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev 26: 417–432.
133. Luo X, Ryu KW, Kim D, Nandu T, Medina CJ, Gupte R, Gibson BA, Soccio RE, Yu Y, Gupta RK, et al. 2017. PARP-1 controls the adipogenic transcriptional program by PARylating C/EBPβ and modulating its transcriptional activity. Mol Cell 65: 260–271.
134. Malet H, Coutard B, Jamal S, Dutartre H, Papageorgiou N, Neuvo-nen M, Ahola T, Forrester N, Gould EA, Lafitte D, et al. 2009. The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol 83: 6534–6545.
135. Martello R, Leutert M, Jungmichel S, Bilan V, Larsen SC, Young C, Hottiger MO, Nielsen ML. 2016. Proteome-wide identification of the endogenous ADP-ribosylome of mammalian cells and tissue. Nat Commun 7: 12917.
136. Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P. 2013. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341: 84–87.
137. Martinez-Zamudio R, Ha HC. 2012. Histone ADP-ribosylation facilitates gene transcription by directly remodeling nucleosomes. Mol Cell Biol 32: 2490–2502.
138. Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, de Murcia G. 1998. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18: 3563–3571.
139. Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, Nava Rodrigues D, Robinson D, Omlin A, Tunariu N, et al. 2015. DNA-repair defects and olaparib in metastatic prostate cancer. N Engl J Med 373: 1697–1708.
140. Messner S, Altmeyer M, Zhao H, Pozivil A, Roschitzki B, Gehrig P, Rutishauser D, Huang D, Caflisch A, Hottiger MO. 2010. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Res 38: 6350–6362.
141. Meyer T, Hilz H. 1986. Production of anti-(ADP-ribose) antibodies with the aid of a dinucleotide-pyrophosphatase-resistant hapten and their application for the detection of mono(ADP-ribosyl)ated polypeptides. Eur J Biochem 155: 157–165.
142. Misteli T, Soutoglou E. 2009. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol 10: 243–254.
143. Moldovan JB, Moran JV. 2015. The zinc-finger antiviral protein ZAP inhibits LINE and Alu retrotransposition. PLoS Genet 11: e1005121.
144. Moyle PM, Muir TW. 2010. Method for the synthesis of mono-ADP-ribose conjugated peptides. J Am Chem Soc 132: 15878–15880.
145. Murawska M, Hassler M, Renkawitz-Pohl R, Ladurner A, Brehm A. 2011. Stress-induced PARP activation mediates recruitment of Drosophila Mi-2 to promote heat shock gene expression. PLoS Genet 7: e1002206.
146. Muthurajan UM, Hepler MR, Hieb AR, Clark NJ, Kramer M, Yao T, Luger K. 2014. Automodification switches PARP-1 function from chromatin architectural protein to histone chaperone. Proc Natl Acad Sci 111: 12752–12757.
147. Niere M, Mashimo M, Agledal L, Dolle C, Kasamatsu A, Kato J, Moss J, Ziegler M. 2012. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose). J Biol Chem 287: 16088–16102.
148. Nusinow DA, Hernandez-Munoz I, Fazzio TG, Shah GM, Kraus WL, Panning B. 2007. Poly(ADP-ribose) polymerase 1 is inhibited by a histone H2A variant, MacroH2A, and contributes to silencing of the inactive X chromosome. J Biol Chem 282: 12851–12859.
149. Oei SL, Shi Y. 2001. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem Biophys Res Commun 285: 27–31.
150. Oka S, Kato J, Moss J. 2006. Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase. J Biol Chem 281: 705–713.
151. Okano S, Lan L, Caldecott KW, Mori T, Yasui A. 2003. Spatial and temporal cellular responses to single-strand breaks in human cells. Mol Cell Biol 23: 3974–3981.
152. Olabisi OA, Soto-Nieves N, Nieves E, Yang TT, Yang X, Yu RY, Suk HY, Macian F, Chow CW. 2008. Regulation of transcription factor NFAT by ADP-ribosylation. Mol Cell Biol 28: 2860–2871.
153. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsi-tohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G. 1999. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18: 4446–4454.
154. Ong CT, Van Bortle K, Ramos E, Corces VG. 2013. Poly(ADP-ribosyl)ation regulates insulator function and intrachromoso-mal interactions in Drosophila. Cell 155: 148–159.
155. Ouararhni K, Hadj-Slimane R, Ait-Si-Ali S, Robin P, Mietton F, Harel-Bellan A, Dimitrov S, Hamiche A. 2006. The histone variant mH2A1.1 interferes with transcription by down-regu-lating PARP-1 enzymatic activity. Genes Dev 20: 3324–3336.
156. Palazzo L, Thomas B, Jemth AS, Colby T, Leidecker O, Feijs KL, Zaja R, Loseva O, Puigvert JC, Matic I, et al. 2015. Processing of protein ADP-ribosylation by Nudix hydrolases. Biochem J 468: 293–301.
157. Palazzo L, Daniels CM, Nettleship JE, Rahman N, McPherson RL, Ong SE, Kato K, Nureki O, Leung AK, Ahel I. 2016. ENPP1 processes protein ADP-ribosylation in vitro. FEBS J 283: 3371–3388.
158. Pavri R, Lewis B, Kim TK, Dilworth FJ, Erdjument-Bromage H, Tempst P, de Murcia G, Evans R, Chambon P, Reinberg D. 2005. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell 18: 83–96.
159. Pekala PH, Lane MD, Watkins PA, Moss J. 1981. On the mechanism of preadipocyte differentiation. Masking of poly(ADP-ri-bose) synthetase activity during differentiation of 3T3-L1 preadipocytes. J Biol Chem 256: 4871–4876.
160. Pellegrino S, Altmeyer M. 2016. Interplay between ubiquitin, SUMO, and poly(ADP-ribose) in the cellular response to genotoxic stress. Front Genet 7: 63.
161. Petesch SJ, Lis JT. 2008. Rapid, transcription-independent loss of nucleosomes over a large chromatin domain at Hsp70 loci. Cell 134: 74–84.
162. Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR. 2000. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 275: 40974–40980.
163. Qiu J, Sheedlo MJ, Yu K, Tan Y, Nakayasu ES, Das C, Liu X, Luo ZQ. 2016. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors. Nature 533: 120–124.
164. Rack JG, Perina D, Ahel I. 2016. Macrodomains: structure, function, evolution, and catalytic activities. Annu Rev Biochem 85: 431–454.
165. Raffaelli N, Sorci L, Amici A, Emanuelli M, Mazzola F, Magni G. 2002. Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem Biophys Res Commun 297: 835–840.
166. Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S, Hottiger MO, Gupta MP. 2009. SIRT1 promotes cell survival under stress by deacetylation-dependent deacti-vation of poly(ADP-ribose) polymerase 1. Mol Cell Biol 29: 4116–4129.
167. Revollo JR, Grimm AA, Imai S. 2004. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransfer-ase regulates Sir2 activity in mammalian cells. J Biol Chem 279: 50754–50763.
168. Riccio AA, Cingolani G, Pascal JM. 2016. PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage. Nucleic Acids Res 44: 1691–1702.
169. Rongvaux A, Andris F, Van Gool F, Leo O. 2003. Reconstructing eukaryotic NAD metabolism. Bioessays 25: 683–690.
170. Rosenthal F, Feijs KL, Frugier E, Bonalli M, Forst AH, Imhof R, Winkler HC, Fischer D, Caflisch A, Hassa PO, et al. 2013. Macrodomain-containing proteins are new mono-ADP-ribo-sylhydrolases. Nat Struct Mol Biol 20: 502–507.
171. Rosenthal F, Nanni P, Barkow-Oesterreicher S, Hottiger MO. 2015. Optimization of LTQ-Orbitrap mass spectrometer parameters for the identification of ADP-ribosylation sites. J Proteome Res 14: 4072–4079.
172. Rouleau M, McDonald D, Gagne P, Ouellet ME, Droit A, Hunter JM, Dutertre S, Prigent C, Hendzel MJ, Poirier GG. 2007. PARP-3 associates with polycomb group bodies and with components of the DNA damage repair machinery. J Cell Biochem 100: 385–401.
173. Rouleau M, Saxena V, Rodrigue A, Paquet ER, Gagnon A, Hendzel MJ, Masson JY, Ekker M, Poirier GG. 2011. A key role for poly(ADP-ribose) polymerase 3 in ectodermal specification and neural crest development. PLoS One 6: e15834.
174. Rulten SL, Fisher AE, Robert I, Zuma MC, Rouleau M, Ju L, Poirier G, Reina-San-Martin B, Caldecott KW. 2011. PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol Cell 41: 33–45.
175. Ryu KW, Kim DS, Kraus WL. 2015. New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases. Chem Rev 115: 2453–2481.
176. Sala A, La Rocca G, Burgio G, Kotova E, Di Gesu D, Collesano M, Ingrassia AM, Tulin AV, Corona DF. 2008. The nucleosome- remodeling ATPase ISWI is regulated by poly-ADP-ribosyla-tion. PLoS Biol 6: e252.
177. Salomon D, Orth K. 2013. What pathogens have taught us about posttranslational modifications. Cell Host Microbe 14: 269–279.
178. Schiewer MJ, Goodwin JF, Han S, Brenner JC, Augello MA, Dean JL, Liu F, Planck JL, Ravindranathan P, Chinnaiyan AM, et al. 2012. Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov 2: 1134–1149.
179. Seo GJ, Kincaid RP, Phanaksri T, Burke JM, Pare JM, Cox JE, Hsiang TY, Krug RM, Sullivan CS. 2013. Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 14: 435–445.
180. Sharifi R, Morra R, Appel CD, Tallis M, Chioza B, Jankevicius G, Simpson MA, Matic I, Ozkan E, Golia B, et al. 2013. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/ C6orf130 in neurodegenerative disease. EMBO J 32: 1225–1237.
181. Slade D, Dunstan MS, Barkauskaite E, Weston R, Lafite P, Dixon N, Ahel M, Leys D, Ahel I. 2011. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 477: 616–620.
182. Specht KM, Shokat KM. 2002. The emerging power of chemical genetics. Curr Opin Cell Biol 14: 155–159.
183. Steffen JD, Brody JR, Armen RS, Pascal JM. 2013. Structural implications for selective targeting of PARPs. Front Oncol 3: 301.
184. Steffen JD, Tholey RM, Langelier MF, Planck JL, Schiewer MJ, Lal S, Bildzukewicz NA, Yeo CJ, Knudsen KE, Brody JR, et al. 2014. Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer. Cancer Res 74: 31–37.
185. Steffen JD, McCauley MM, Pascal JM. 2016. Fluorescent sensors of PARP-1 structural dynamics and allosteric regulation in response to DNA damage. Nucleic Acids Res 44: 9771–9783.
186. Teloni F, Altmeyer M. 2016. Readers of poly(ADP-ribose): designed to be fit for purpose. Nucleic Acids Res 44: 993–1006.
187. Thomas HD, Calabrese CR, Batey MA, Canan S, Hostomsky Z, Kyle S, Maegley KA, Newell DR, Skalitzky D, Wang LZ, et al. 2007. Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial. Mol Cancer Ther 6: 945–956.
188. Thorsell AG, Ekblad T, Karlberg T, Low M, Pinto AF, Tresaugues L, Moche M, Cohen MS, Schuler H. 2016. Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors. J Med Chem doi: 10.1021/acs.jmedchem.6b00990.
189. Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, Nij-meijer B, Colombelli J, Altmeyer M, Stelzer EH, Scheffzek K, et al. 2009. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat Struct Mol Biol 16: 923–929.
190. Todorova T, Bock FJ, Chang P. 2014. PARP13 regulates cellular mRNA post-transcriptionally and functions as a pro-apoptotic factor by destabilizing TRAILR4 transcript. Nat Commun 5: 5362.
191. Tong L, Denu JM. 2010. Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim Biophys Acta 1804: 1617–1625.
192. Tulin A, Spradling A. 2003. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 299: 560–562.
193. Tulin A, Naumova NM, Menon AK, Spradling AC. 2006. Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing. Genetics 172: 363–371.
194. van der Heden, van Noort GJ, van der Horst MG, Overkleeft HS, van der Marel GA, Filippov DV. 2010. Synthesis of mono- ADP-ribosylated oligopeptides using ribosylated amino acid building blocks. J Am Chem Soc 132: 5236–5240.
195. Verheugd P, Forst AH, Milke L, Herzog N, Feijs KL, Kremmer E, Kleine H, Luscher B. 2013. Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10. Nat Commun 4: 1683.
196. Vivelo CA, Wat R, Agrawal C, Tee HY, Leung AK. 2016. ADP-riboDB: the database of ADP-ribosylated proteins. Nucleic Acids Res 45: D204–D209.
197. Vyas S, Chesarone-Cataldo M, Todorova T, Huang YH, Chang P. 2013. A systematic analysis of the PARP protein family identifies new functions critical for cell physiology. Nat Commun 4: 2240.
198. Vyas S, Matic I, Uchima L, Rood J, Zaja R, Hay RT, Ahel I, Chang P. 2014. Family-wide analysis of poly(ADP-ribose) polymerase activity. Nat Commun 5: 4426.
199. Wahlberg E, Karlberg T, Kouznetsova E, Markova N, Macchiarulo A, Thorsell AG, Pol E, Frostell A, Ekblad T, Oncu D, et al. 2012. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol 30: 283–288.
200. Wang Z, Michaud GA, Cheng Z, Zhang Y, Hinds TR, Fan E, Cong F, Xu W. 2012. Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination. Genes Dev 26: 235–240.
201. Wang Y, Zhang T, Kwiatkowski N, Abraham BJ, Lee TI, Xie S, Yuzugullu H, Von T, Li H, Lin Z, et al. 2015. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell 163: 174–186.
202. Wang Y, An R, Umanah GK, Park H, Nambiar K, Eacker SM, Kim B, Bao L, Harraz MM, Chang C, et al. 2016. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science 354: aad6872.
203. Welsby I, Hutin D, Gueydan C, Kruys V, Rongvaux A, Leo O. 2014. PARP12, an interferon-stimulated gene involved in the control of protein translation and inflammation. J Biol Chem 289: 26642–26657.
204. Westcott NP, Fernandez JP, Molina H, Hang HC. 2017. Chemical proteomics reveals ADPribosylation of small GTPases during oxidative stress. Nat Chem Biol doi: 10.1038/nchembio.2280.
205. Wright RH, Lioutas A, Le Dily F, Soronellas D, Pohl A, Bonet J, Nacht AS, Samino S, Font-Mateu J, Vicent GP, et al. 2016. ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling. Science 352: 1221–1225.
206. Wu C. 1997. Chromatin remodeling and the control of gene expression. J Biol Chem 272: 28171–28174.
207. +/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10: 179–206.
208. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. 2002. Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259–263.
209. Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, Docquier F, Farrar D, Tavoosidana G, Mukhopadhyay R, Kanduri C, et al. 2004. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 36: 1105–1110.
210. Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL, Zhang H. 2003. Structural characterization of a human cy-tosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 278: 13503–13511.
211. + salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem 284: 20408–20417.
212. Zhang Y, Liu S, Mickanin C, Feng Y, Charlat O, Michaud GA, Schirle M, Shi X, Hild M, Bauer A, et al. 2011. RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol 13: 623–629.
213. + synthase. J Biol Chem 287: 12405–12416.
214. Zhang Y, Wang J, Ding M, Yu Y. 2013. Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome. Nat Methods 10: 981–984.
215. Zhang Y, Mao D, Roswit WT, Jin X, Patel AC, Patel DA, Agapov E, Wang Z, Tidwell RM, Atkinson JJ, et al. 2015. PARP9DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat Immunol 16: 1215–1227.
216. Zhao H, Sifakis EG, Sumida N, Millan-Arino L, Scholz BA, Svensson JP, Chen X, Ronnegren AL, Mallet de Lima CD, Varnoos-faderani FS, et al. 2015. PARP1- and CTCF-mediated interactions between active and repressed chromatin at the lamina promote oscillating transcription. Mol Cell 59: 984–997.
217. + glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem Biophys Res Commun 196: 1459–1465.